Statements (32)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
Zydus Cadila
|
| gptkbp:awards |
various industry awards
|
| gptkbp:certifications |
gptkb:MHRA
gptkb:ISO_9001 gptkb:US_FDA gptkb:WHO_GMP |
| gptkbp:communityInvolvement |
education programs
environmental sustainability efforts healthcare_initiatives |
| gptkbp:employees |
over 1000
|
| gptkbp:exportedTo |
to over 70 countries
|
| gptkbp:focus |
quality and safety
|
| gptkbp:founded |
2007
|
| gptkbp:headquarters |
Bengaluru,_India
|
| https://www.w3.org/2000/01/rdf-schema#label |
Claris Injectables
|
| gptkbp:market |
global
|
| gptkbp:mission |
improve patient outcomes
|
| gptkbp:partnerships |
various healthcare organizations
|
| gptkbp:productionCompany |
state-of-the-art facilities
|
| gptkbp:productLine |
branded injectables
generic injectables |
| gptkbp:products |
nutritional products
oncology drugs anti-infectives anesthesia drugs critical care drugs |
| gptkbp:researchAndDevelopment |
strong emphasis
|
| gptkbp:specializesIn |
injectable medications
|
| gptkbp:supplyChain |
integrated supply chain
|
| gptkbp:vision |
be a global leader in injectables
|
| gptkbp:website |
www.clarisinjectables.com
|